Analysts' Actions: FB, MA, NWSA, PG, DSW

NEW YORK ( TheStreet) -- CHANGE IN RATINGS

Chubb ( CB) upgraded at S&P from Hold to Buy, Standard & Poors said. $80 price target. Company trades at a discount to its peers.

DSW ( DSW) rated new Buy at Brean Murray. $65 price target. Recent pullback has created an attractive buying opportunity.

Facebook ( FB) rated new Neutral at Citigroup. $35 price target. Significant long term potential offset by medium term risk.

Facebook rated new Overweight at Morgan Stanley. $38 price target. Company can leverage its user base and monetize the mobile Internet.

Facebook rated new Neutral at Credit Suisse.Valuation call, based on a $34 price target.

Facebook rated new Buy at Goldman Sachs. $42 price target. Social media is ushering in the next era of the web and the company can dominate this.

Facebook rated new Overweight at JP Morgan. $45 price target. Ad platform is growing stronger and the company should be able to monetize the mobile market.

Facebook rated new Neutral at BofA/Merrill. $38 price target. Cautious on near-term sales trends.

Hasbro ( HAS) downgraded at Citigroup to Sell from Neutral, Citigroup said. $31 price target. Core businesses are largely underperforming.

Heartland Payment ( HPY) upgraded at KBW from Market Perform to Outperform. Valuation call, based on a $34 price target.

Nordstrom ( JWN) downgraded at Citigroup to Neutral from Buy, Citigroup said. $52 price target. Cautious 2H outlook.

Macy's ( M) downgraded at Citigroup to Neutral from Buy, Citigroup said. $37 price target. Unlikely to be star performer in 2H12.

Nvidia ( NVDA) upgraded at S&P from Hold to Buy, Standard & Poors said. Sales of the new Tegra 3 processor should begin to ramp in the second half of the year.

News Corp. ( NWSA) upgraded at Needham from Hold to Buy, Needham said. $27 price target. Spin-off could create more than $5 a share of value.

Riverbed Technology ( RVBD) upgraded at Jefferies to Hold from Underweight, Jefferies said. $14 price target. Risk/reward now evenly balanced.

Saks ( SKS) downgraded at Citigroup to Neutral from Buy, Citigroup said. $11 price target. Stepping to sidelines as high end strength fades.

Varian Medical ( VAR) rated new Buy at Nomura. $70 price target. Sector has limited competition and long-term growth potential.

ValueClick ( VCLK) upgraded at Benchmark from Hold to Buy, Benchmark said. $20 price target. Company has solid growth prospects and the stock is attractive following a recent pullback.

STOCK COMMENTS / EPS CHANGES

Amarin Corporation ( AMRN) target raised at Jefferies to $26, Jefferies said. Bullish on near-term approval of AMR101.

Flowserve ( FLS) numbers raised at UBS. Shares of FLS now seen reaching $146, UBS said. Estimates also increased as repo impact exceeds FX pressure.

Mastercard ( MA) estimates cut at FBR through 2013, FBR Capital Markets said. Company is being hurt by a stronger dollar. Outperform rating and $520 price target.

MSC Industrial ( MSM) numbers cut at UBS.Shares of MSM now seen reaching $83, UBS said. Estimates also lowered as recent manufacturing data warrants some added caution. Buy rating.

Procter & Gamble ( PG) numbers cut at Deutsche. Shares of PG now seen reaching $67, according to Deutsche Bank. Estimates also reduced, given currency headwinds. Buy rating.

>To submit a news tip, email: tips@thestreet.com.

READERS ALSO LIKE:


Follow TheStreet on Twitter and become a fan on Facebook.

This article was written by a staff member of TheStreet.

More from Stocks

A Thunderous Herd of Scared Baby Boomer Investors Could Crush the Market

A Thunderous Herd of Scared Baby Boomer Investors Could Crush the Market

With GE Dropped From the Dow, Be Selective About Industrials Stocks

With GE Dropped From the Dow, Be Selective About Industrials Stocks

Dow Rises as Blue-Chip Index Looks to End Losing Streak

Dow Rises as Blue-Chip Index Looks to End Losing Streak

3 Ways to Fix Starbucks Biggest Challenges

3 Ways to Fix Starbucks Biggest Challenges

General Electric's Boot From the Dow: Is This as Bad as It Can Get?

General Electric's Boot From the Dow: Is This as Bad as It Can Get?